Display Settings:

Format

Send to:

Choose Destination
IDrugs. 2005 Sep;8(9):755-62.

LY-544344. Eli Lilly.

Author information

  • Merz Pharmaceuticals GmbH, Department of Behavioural Pharmacology, Eckenheimer Landstrasse 100, Frankfurt am Main, D-30618, Germany. Wojciech.Danysz@merz.de

Abstract

Eli Lilly and Co is developing LY-544344, a prodrug of the metabotropic glutamate receptor 2/3 agonist LY-354740, for the potential treatment of anxiety disorders.

PMID:
16118698
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk